Keio University Hospital
Shinjuku Ku, Tokyo, Japan
University hospital in Shinjuku, Tokyo
〒160-8582 Tokyo, Shinjuku City, Shinanomachi, ３５
About Keio University Hospital
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Pfizer
22
Hoffmann-La Roche
8
Takeda
7
Merck Sharp & Dohme LLC
5
Shire
5
Bristol-Myers Squibb
4
Eli Lilly and Company
4
Incyte Corporation
4
Keio University
4
Amgen
3
Bayer
3
Clinical Trials at Keio University Hospital
During the past decade, Keio University Hospital conducted 107 clinical trials. In the 10-year time frame, 107 clinical trials started and 50 clinical trials were completed, i.e. on
average, 46.7% percent of trials that started reached the finish line to date. In the past 5 years, 42 clinical trials started and 32 clinical trials were completed. i.e. 76.2%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Efficacy and Safety Study of Argatroban to Treat Heparin-Induced Thrombocytopenia
2005-06-01
2006-09-01
Completed
8
Phase III Study of Docetaxel + S-1 vs. S-1 for Advanced Gastric Cancer
2006-03-01
2010-10-01
Completed
628
Epirubicin and Cyclophosphamide Followed By Docetaxel and Trastuzumab in Treating Women With HER2-Positive Stage III or Stage IV Breast Cancer
2006-01-01
2016-03-01
Completed
38
Investigation in Myositis-associated Pneumonitis of Prednisolone And Concomitant Tacrolimus
2007-07-01
2011-01-01
Completed
25
Safety Study of Lenalidomide With and Without Dexamethasone in Japanese Subjects With Previously Treated Multiple Myeloma
2007-07-01
2010-12-01
Completed
15
Second Line Chemotherapy for S-1 Refractory Advanced Gastric Cancer
2008-03-01
2011-06-01
Completed
300
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Keio University Hospital" #1 sponsor was "Pfizer" with 22 trials, followed by "Hoffmann-La Roche" with 8 trials
sponsored, "Takeda" with 7 trials sponsored, "Merck Sharp & Dohme LLC" with 5 trials sponsored and "Shire"
with 5 trials sponsored. Other sponsors include 98 different institutions and
companies that sponsored additional 72 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Keio University Hospital"
#1 collaborator was "Astellas Pharma Inc" with 4 trials as a collaborator, "Merck Sharp & Dohme LLC" with 3 trials as a collaborator, "Eisai Inc." with 2 trials as a collaborator, "Eli Lilly and Company" with 2 trials as a collaborator and "Galapagos NV" with 2 trials as a collaborator. Other collaborators include 77 different institutions and companies that were
collaborators in the rest 80 trials.
Clinical Trials Conditions at Keio University Hospital
According to Clinical.Site data, the most researched conditions in "Keio University Hospital" are
"Crohn's Disease" (6 trials), "Rheumatoid Arthritis" (5 trials), "Systemic Lupus Erythematosus" (5 trials), "Ulcerative Colitis" (5 trials) and "Carcinoma, Renal Cell" (4 trials). Many other conditions were trialed in "Keio University Hospital" in a lesser frequency.
Clinical Trials Intervention Types at Keio University Hospital
Most popular intervention types in "Keio University Hospital" are "Drug" (123 trials), "Device" (17 trials), "Other" (14 trials), "Biological" (13 trials) and "Procedure" (6 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (35 trials), "Atezolizumab" (8 trials), "Pembrolizumab" (7 trials), "Bevacizumab" (5 trials) and "Carboplatin" (4 trials). Other intervention names were less common.
Clinical Trials Genders at Keio University Hospital
The vast majority of trials in "Keio University Hospital" are
130 trials for "All" genders, 12 trials for "Female" genders and 8 trials for "Male" genders.
Clinical Trials Status at Keio University Hospital
Currently, there are NaN active trials in "Keio University Hospital".
1 are not yet recruiting,
28 are recruiting,
33 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 72 completed trials in Keio University Hospital,
undefined suspended trials,
and 14 terminated clinical trials to date.
Out of the total trials that were conducted in Keio University Hospital, 7 "Phase 1"
clinical trials were conducted, 40 "Phase 2" clinical
trials and 84 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 6 trials, and there were
also 12 trials that are defined as “Not Applicable".